The DOI matches its Crossref record; 127 of the 128 references it cites were found in a registry or an index.
Multi-domain interventions for the prevention of dementia and cognitive decline
Open accessAbstract
BACKGROUND: Dementia is a worldwide concern. Its global prevalence is increasing. Currently, no effective medical treatment exists to cure or to delay the onset of cognitive decline or dementia. Up to 40% of dementia is attributable to potentially modifiable risk factors, which has led to the notion that targeting these risk factors might reduce the incidence of cognitive decline and dementia. Since sporadic dementia is a multifactorial condition, thought to derive from multiple causes and risk factors, multi-domain interventions may be more effective for the prevention of dementia than those targeting single risk factors. OBJECTIVES: To assess the effects of multi-domain interventions for the prevention of cognitive decline and dementia in older adults, including both unselected populations and populations at increased risk of cognitive decline and dementia. SEARCH METHODS: We searched ALOIS, the Cochrane Dementia and Cognitive Improvement Group's register, MEDLINE (Ovid SP), Embase (Ovid SP), PsycINFO (Ovid SP), CINAHL (EBSCOhost), Web of Science Core Collection (ISI Web of Science), LILACS (BIREME), and ClinicalTrials.gov on 28 April 2021. We also reviewed citations of reference lists of included studies, landmark papers, and review papers to identify additional studies and assessed their suitability for inclusion in the review. SELECTION CRITERIA: We defined a multi-domain intervention as an intervention with more than one component, pharmacological or non-pharmacological, but not consisting only of two or more drugs with the same therapeutic target. We included randomised controlled trials (RCTs) evaluating the effect of such an intervention on cognitive functioning and/or incident dementia. We accepted as control conditions any sham intervention or usual care, but not single-domain interventions intended to reduce dementia risk. We required studies to have a minimum of 400 participants and an intervention and follow-up duration of at least 12 months. DATA COLLECTION AND ANALYSIS: We initially screened search results using a 'crowdsourcing' method in which members of Cochrane's citizen science platform identify RCTs. We screened the identified citations against inclusion criteria by two review authors working independently. At least two review authors also independently extracted data, assessed the risk of bias and applied the GRADE approach to assess the certainty of evidence. We defined high-certainty reviews as trials with a low risk of bias across all domains other than blinding of participants and personnel involved in administering the intervention (because lifestyle interventions are difficult to blind). Critical outcomes were incident dementia, incident mild cognitive impairment (MCI), cognitive decline measured with any validated measure, and mortality. Important outcomes included adverse events (e.g. cardiovascular events), quality of life, and activities of daily living (ADL). Where appropriate, we synthesised data in random-effects meta-analyses. We expressed treatment effects as risk ratios (RRs) and mean differences (MDs) with 95% confidence intervals (CIs). MAIN RESULTS: We included nine RCTs (18.452 participants) in this review. Two studies reported incident dementia as an outcome; all nine studies reported a measure for cognitive functioning. Assessment of cognitive functioning was very heterogeneous across studies, ranging from complete neuropsychological assessments to short screening tests such as the mini-mental state examination (MMSE). The duration of the interventions varied from 12 months to 10 years. We compared multi-domain interventions against usual care or a sham intervention. Positive MDs and RRs <1 favour multi-domain interventions over control interventions. For incident dementia, there was no evidence of a difference between the multi-domain intervention group and the control group (RR 0.94, 95% CI 0.76 to 1.18; 2 studies; 7256 participants; high-certainty evidence). There was a small difference in composite Z-score for cognitive function measured with a neuropsychological test battery (NTB) (MD 0.03, 95% CI 0.01 to 0.06; 3 studies; 4617 participants; high-certainty evidence) and with the Montreal Cognitive Assessment (MoCA) scale (MD 0.76 point, 95% CI 0.05 to 1.46; 2 studies; 1554 participants), but the certainty of evidence for the MoCA was very low (due to serious risk of bias, inconsistency and indirectness) and there was no evidence of an effect on the MMSE (MD 0.02 point, 95% CI -0.06 to 0.09; 6 studies; 8697participants; moderate-certainty evidence). There was no evidence of an effect on mortality (RR 0.93, 95% CI 0.84 to 1.04; 4 studies; 11,487 participants; high-certainty evidence). There was high-certainty evidence for an interaction of the multi-domain i
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This Cochrane review assessed whether multi-domain interventions prevent cognitive decline and dementia in older adults, pooling nine RCTs (18,452 participants). It found no evidence of an effect on incident dementia, but a small improvement in cognitive function measured by a neuropsychological test battery, with the strongest effects in trials that included cognitive training.
Key findings
- No evidence of a difference in incident dementia between multi-domain intervention and control groups (RR 0.94, 95% CI 0.76 to 1.18; 2 studies; 7256 participants; high-certainty evidence).
- Small improvement in composite Z-score for cognitive function on a neuropsychological test battery (MD 0.03, 95% CI 0.01 to 0.06; 3 studies; 4617 participants; high-certainty evidence), and on the MoCA (MD 0.76 point, 95% CI 0.05 to 1.46; 2 studies; 1554 participants; very low-certainty evidence).
- No evidence of an effect on MMSE (MD 0.02 point, 95% CI -0.06 to 0.09; 6 studies; 8697 participants; moderate-certainty evidence) or on mortality (RR 0.93, 95% CI 0.84 to 1.04; 4 studies; 11,487 participants; high-certainty evidence).
- High-certainty evidence for an interaction with ApoE4 status on NTB cognitive function (carriers MD 0.14, 95% CI 0.04 to 0.25; noncarriers MD 0.04, 95% CI -0.02 to 0.10; P for interaction 0.09); no clear interaction with baseline MMSE (P for interaction 0.12) or clear effect in those with CAIDE score > 6 (MD 0.07, 95% CI -0.00 to 0.15).
Methods
- Systematic review and random-effects meta-analysis of RCTs; multi-domain intervention defined as more than one component (pharmacological or non-pharmacological), excluding two or more drugs with the same therapeutic target; controls were sham intervention or usual care.
- Searched ALOIS, MEDLINE, Embase, PsycINFO, CINAHL, Web of Science, LILACS, and ClinicalTrials.gov on 28 April 2021; required ≥400 participants and ≥12 months intervention/follow-up.
- Two review authors independently screened, extracted data, assessed risk of bias, and applied GRADE; effects expressed as risk ratios and mean differences with 95% CIs.
Limitations
- Stated: incident dementia conclusions rest on only two trials; cognitive assessment was very heterogeneous (from full neuropsychological batteries to short screening tests); interventions varied in components and intensity; the NTB effect was strongest in trials offering cognitive training, making a learning effect difficult to rule out.
- Stated: MoCA evidence was very low certainty due to serious risk of bias, inconsistency, and indirectness.
- Evident from the text: intervention durations ranged widely (12 months to 10 years), and the review's conclusions on dementia prevention are limited by the small number of trials reporting that outcome.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
13 Own result · 4 Own method · 2 Own interpretation · 1 No basis given
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no clear evidence for an interaction with baseline cognitive status (defined by MMSE-score) on cognitive function measured with an NTB (low baseline MMSE group MD 0.06, 95% CI 0.01 to 0.11, high baseline MMSE group MD 0.01, 95% CI -0.01 to 0.04, P for interaction 0.12)”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“there was no evidence of an effect on the MMSE (MD 0.02 point, 95% CI -0.06 to 0.09; 6 studies; 8697participants; moderate-certainty evidence)”
plainn = 8,697- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“nor was there clear evidence for an effect in participants with a Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) score > 6 points (MD 0.07, 95%CI -0.00 to 0.15).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We included nine RCTs (18.452 participants) in this review.”
plainn = 18,452- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no evidence of an effect on mortality (RR 0.93, 95% CI 0.84 to 1.04; 4 studies; 11,487 participants; high-certainty evidence).”
plainn = 11,487- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“although this effect was strongest in trials offering cognitive training within the multi-domain intervention”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For incident dementia, there was no evidence of a difference between the multi-domain intervention group and the control group (RR 0.94, 95% CI 0.76 to 1.18; 2 studies; 7256 participants; high-certainty evidence).”
plainn = 7,256- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was high-certainty evidence for an interaction of the multi-domain intervention with ApoE4 status on the outcome of cognitive function measured with an NTB (carriers MD 0.14, 95% CI 0.04 to 0.25, noncarriers MD 0.04, 95% CI -0.02 to 0.10, P for interaction 0.09).”
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found no evidence that multi-domain interventions can prevent incident dementia based on two trials.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“making it difficult to rule out a potential learning effect”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
- Probably not a substantial claim. 7
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the Montreal Cognitive Assessment (MoCA) scale (MD 0.76 point, 95% CI 0.05 to 1.46; 2 studies; 1554 participants), but the certainty of evidence for the MoCA was very low (due to serious risk of bias, inconsistency and indirectness)”
plaincorrelationaln = 1,554- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was a small improvement in cognitive function assessed by a NTB in the group of participants receiving a multi-domain intervention”
plaindirectn = 4,617- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Interventions were diverse in terms of their components and intensity.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Assessment of cognitive functioning was very heterogeneous across studies, ranging from complete neuropsychological assessments to short screening tests such as the mini-mental state examination (MMSE).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The duration of the interventions varied from 12 months to 10 years.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Two studies reported incident dementia as an outcome; all nine studies reported a measure for cognitive functioning.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“At least two review authors also independently extracted data, assessed the risk of bias and applied the GRADE approach to assess the certainty of evidence.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“At least two review authors also independently extracted data, assessed the risk of bias and applied the GRADE approach to assess the certainty of evidence.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“We screened the identified citations against inclusion criteria by two review authors working independently.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“At least two review authors also independently extracted data, assessed the risk of bias and applied the GRADE approach to assess the certainty of evidence.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper relies on this without support.
Up to 40% of dementia is attributable to potentially modifiable risk factors.
“Up to 40% of dementia is attributable to potentially modifiable risk factors”
The paper relies on this without support.
Sporadic dementia is a multifactorial condition deriving from multiple causes and risk factors.
“Since sporadic dementia is a multifactorial condition, thought to derive from multiple causes and risk factors”
The paper relies on this without support.
Multi-domain interventions may be more effective for the prevention of dementia than interventions targeting single risk factors.
“multi-domain interventions may be more effective for the prevention of dementia than those targeting single risk factors”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A 2021 Cochrane review identified nine multi-domain interventions for the prevention of dementia or cognitive decline RCTs with 18,452 participants.(260)”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [260]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“There was high certainty of a small benefit on overall cognition (3 RCTs; composite z score mean difference (MD) 0.03, 0.01- 0.06, n = 4,617, over 18-36 months), (228, 261, 262)”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [260]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“particularly in people with the APOE ε 4 genotype (2 RCTs; n = 2,043, follow-up 24-36 months, carriers MD 0.14, 0.04 -0.25, noncarriers MD 0.04, -0.02 to 0.10,)”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [260]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Although a UKB study of 300,823 people found that those with cataracts had an increased risk of dementia (HR, 1.2, 1.01 -1.46)”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [255]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“but that there was no difference in dementia risk between those who had cataract surgery and healthy controls.(255)”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [255]
Experimental — accuracy not yet measured
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Dementia is characterised by progressive cognitive impairment that impacts daily activity, with prevalence in the UK projected to increase to over 2 million by 2051 [3, 4].”
From Do hospital-to-home transitions work for older adults with multiple long-term conditions including dementia? A realist review (2025) · cites this paper as [3]
Experimental — accuracy not yet measured
Citations
Cites
1 retracted
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
RetractedPreferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,762
Cochrane Handbook for Systematic Reviews of Interventions
(2019) · doi:10.1002/9781119536604 · Cited by 14,828
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Sick individuals and sick populations
Rose, G. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.3.427 · Cited by 3,736
Ngandu, T., Lehtisalo, J., Solomon, A., Levälahti, E., Ahtiluoto, S., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., Laatikainen, T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60461-5 · Cited by 3,689
Research works printed but not linked: 5
- Hayden, 2018, The action for health in diabetes clinical trial: does a 10-year intensive multidomain lifestyle intervention provide cognitive benefits?, Journal of Prevention of Alzheimer's Disease, Conference: 11t, S64
- Manfredi, 2013, Non-pharmacological treatment in cognitive decline: cognitive and behavioural outcomes, Behavioural Neurology, 27 (3), 373
- Solomon, 2018, Effects of a multidomain lifestyle intervention on overall risk for dementia: the Finger randomized controlled trial, Alzheimer's and Dementia, 14 (7 Supplemen, P1024
- Peters, 2013, Republished research: Implementation research: what it is and how to do it, BMJ, 347, 731
- Review Manager Web (RevMan Web) The Cochrane Collaboration 2021
Cited by
Sorted by citations
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01296-0 · Cited by 3,860
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
Martin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z., Anderson, C. A. M., Arora, P. K., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001303 · Cited by 1,284
Izquierdo, M., de Souto Barreto, P., Arai, H., Bischoff-Ferrari, H. A., Cadore, E. L., Cesari, M., Chen, L.-K., Coen, P. M., Courneya, K. S., Duque, G., et al. (2025) · The Journal of nutrition, health and aging · doi:10.1016/j.jnha.2024.100401 · Cited by 273
Palaniappan, L. P., Allen, N. B., Almarzooq, Z., Anderson, C. A. M., Arora, P. K., Avery, C. L., Baker-Smith, C. M., Bansal, N., Currie, M. E., Earlie, R. S., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001412 · Cited by 343
Social participation and risk of developing dementia
Sommerlad, A., Kivimäki, M., Larson, E. B., Röhr, S., Shirai, K., Singh-Manoux, A., & Livingston, G. (2023) · Nature Aging · doi:10.1038/s43587-023-00387-0 · Cited by 207
Li, R., Li, R., Xie, J., Chen, J., Liu, S., Pan, A., & Liu, G. (2023) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(23)00211-8 · Cited by 164
Yaffe, K., Vittinghoff, E., Dublin, S., Peltz, C. B., Fleckenstein, L. E., Rosenberg, D. E., Barnes, D. E., Balderson, B. H., & Larson, E. B. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.6279 · Cited by 124
Japan‐Multimodal Intervention Trial for the Prevention of Dementia: A randomized controlled trial
Sakurai, T., Sugimoto, T., Akatsu, H., Doi, T., Fujiwara, Y., Hirakawa, A., Kinoshita, F., Kuzuya, M., Lee, S., Matsumoto, N., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13838 · Cited by 111
Zülke, A. E., Pabst, A., Luppa, M., Roehr, S., Seidling, H., Oey, A., Cardona, M. I., Blotenberg, I., Bauer, A., Weise, S., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13486 · Cited by 90
Brodaty, H., Chau, T., Heffernan, M., Ginige, J. A., Andrews, G., Millard, M., Sachdev, P. S., Anstey, K. J., Lautenschlager, N. T., McNeil, J. J., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03351-6 · Cited by 97
What would a population‐level approach to dementia risk reduction look like, and how would it work?
Walsh, S., Govia, I., Peters, R. K., Richard, E., Stephan, B. C. M., Wilson, N., Wallace, L. M. K., Anstey, K. J., & Brayne, C. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12985 · Cited by 69
Self-citationColey, N., Giulioli, C., Aisen, P. S., Vellas, B., & Andrieu, S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101777 · Cited by 62
Reparaz-Escudero, I., Izquierdo, M., Bischoff-Ferrari, H. A., Martínez-Lage, P., & Sáez de Asteasu, M. L. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102463 · Cited by 45
Therapeutic approaches for improving cognitive function in the aging brain
Chen, L., Jiao, J., & Zhang, Y. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1060556 · Cited by 42
Factors associated with cognitive reserve according to education level
Kim, Y., Stern, Y., Seo, S. W., Na, D. L., Jang, J., & Jang, H. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14236 · Cited by 48
The Impact of Cognitive Impairment on Cardiovascular Disease
Jamil, Y., Krishnaswami, A., Orkaby, A. R., Stimmel, M. B., Brown, C. H., Mecca, A. P., Forman, D. E., Rich, M. W., Nanna, M. G., & Damluji, A. A. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.04.057 · Cited by 40
An 18‐month multimodal intervention trial for preventing dementia: J‐MINT PRIME Tamba
Oki, Y., Osaki, T., Kumagai, R., Murata, S., Encho, H., Ono, R., Yasuda, H., & Kowa, H. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14170 · Cited by 41
Zülke, A. E., Pabst, A., Luppa, M., Oey, A., Weise, S., Fankhänel, T., Kosilek, R. P., Schillok, H., Brettschneider, C., Czock, D., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14097 · Cited by 32
van Charante, E. P. M., Hoevenaar‐Blom, M. P., Song, M., Andrieu, S., Barnes, L., Birck, C., Brooks, R., Coley, N., Eggink, E., Georges, J., et al. (2024) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(24)00068-0 · Cited by 29
Self-citationAndrews, V., Zammit, G., & O’Leary, F. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad013 · Cited by 28
Current and Future Treatments of Vascular Cognitive Impairment
Ip, B. Y. M., Ko, H., Lam, B. Y. K., Au, L. W. C., Lau, A. Y. L., Huang, J., Kwok, A. J., Leng, X., Cai, Y., Leung, T. W. H., et al. (2024) · Stroke · doi:10.1161/strokeaha.123.044174 · Cited by 27
Lü, Y., Liu, C., Fawkes, S. A., Wang, Z., & Yu, D. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01716-9 · Cited by 29
Walsh, S., Wallace, L., Kuhn, I., Mytton, O., Lafortune, L., Wills, W., Mukadam, N., & Brayne, C. (2023) · The journal of prevention of Alzheimer's disease · doi:10.14283/jpad.2023.57 · Cited by 26
Duan, S., Chen, D., Wang, J., Paramboor, M. S., Xia, Z., Xu, W., Han, K., Zhu, T., & Jiang, X. (2024) · Journal of Medical Internet Research · doi:10.2196/56636 · Cited by 22
Sugimoto, T., Araki, A., Fujita, H., Fujita, K., Honda, K., Inagaki, N., Ishida, T., Kato, J., Kishi, M., Kishino, Y., et al. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.117 · Cited by 23
Kempermann, G. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.841393 · Cited by 24
Healthy brain aging and delayed dementia in Texas rural elderly
Basu, T., Sehar, U., Malhotra, K., Culberson, J. W., Khan, H. M. R., Morton, H., Orlov, E., Brownell, M., & Reddy, P. H. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102047 · Cited by 24
Braun, A. L., Höfler, M., & Auer, S. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.12 · Cited by 19
Wang, Y.-Y., Wang, X.-X., Chen, L., Liu, Y., & Li, Y. (2023) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2023.103635 · Cited by 19
A Scoping Review on the Opportunities for Social Engagement and Cognitive Frailty in Older Adults
Fowler‐Davis, S., Benkowitz, C., Holland, C., Gow, A. J., & Clarke, C. (2024) · Public health reviews · doi:10.3389/phrs.2024.1606494 · Cited by 22
Grigas, O., Maskeliūnas, R., & Damaševičius, R. (2024) · Health technology · doi:10.1007/s12553-024-00823-0 · Cited by 16
Jiang, B., Liu, Q., Li, J.-P., Lin, S.-N., Wan, H., Yu, Z.-W., Wang, J., Zhuang, W., Tang, J.-H., Chen, C., et al. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-05054-6 · Cited by 21
Zülke, A. E., Riedel-Heller, S. G., Wittmann, F., Pabst, A., Röhr, S., & Luppa, M. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.80 · Cited by 16
Lawson, L., Ardle, R. M., Wilson, S., Beswick, E., Karimi, R., & Slight, S. P. (2023) · Journal of Medical Internet Research · doi:10.2196/45658 · Cited by 19
Ishimoto, T., Yamashita, R., Matsumoto, R., Matsumoto, S., Matsuo, Y., Nakao, S., Masuo, Y., Suzuki, M., & Kato, Y. (2024) · npj Science of Food · doi:10.1038/s41538-024-00250-5 · Cited by 18
Tackling vascular risk factors as a possible disease modifying intervention in Parkinson’s disease
Visser, A. E., de Vries, N. M., Richard, E., & Bloem, B. R. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00666-6 · Cited by 14
Self-citationLicher, S., Wolters, F. J., Pavlović, J., Kavousi, M., Leening, M. J. G., Ikram, M. K., & Ikram, M. A. (2023) · Neuroepidemiology · doi:10.1159/000528120 · Cited by 13
Lin, X. C., Xu, G., Zhao, M., & Jiang, Y. (2025) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2025.105129 · Cited by 13
Sakurai, T., Sugimoto, T., & Arai, H. (2025) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.70088 · Cited by 12
Lawson, L., Cooper, M., Tolley, C., Hand, A., & Nazar, H. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-06123-0 · Cited by 10
de Souza-Lima, J., Matsudo, S. M., Valdívia-Moral, P., Pérez, W., Drenowatz, C. J., Zenteno, J. S., & Ferrari, G. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-04410-2 · Cited by 10
Vásquez-Carrasco, E., Rojas, M., Larenas, L., Ferrada, A., Hernandez-Martinez, J., Ahumada-Méndez, F., Bianchi, M. L., Carmine, F., Sandoval, C., Branco, B. H. M., et al. (2025) · Medicina · doi:10.3390/medicina61040583 · Cited by 10
Actividades preventivas en el mayor. Actualización PAPPS 2022
Benito, M. Á. A., Pliego, R. A. G., Baena-Díez, J. M., Iturbe, A. G., Herreros, Y. H., Alonso, M. D. C. D. H., Tapia, P. M., & Lesende, I. M. (2022) · Atención Primaria · doi:10.1016/j.aprim.2022.102438 · Cited by 9
From Dementia to Eumentia: A New Approach to Dementia Prevention
Hachinski, V., & Avan, A. (2022) · Neuroepidemiology · doi:10.1159/000525219 · Cited by 10
Alcalá‐Lozano, R., Carmona-Hernández, R., Ocampo-Romero, A. G., Sosa-Millán, A. L., Morelos-Santana, E., Abarca, D. Z., Aquino, D. V. C.-D., Cabrera-Muñoz, E. A., Ramírez-Rodríguez, G. B., Sosa, A. L., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041754 · Cited by 8
Cheng, X. W., Zhang, K., Liu, J., Hu, J., Yuan, Q., Cai, H., Hu, H., Liao, D., & Lin, L. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1526086 · Cited by 7
Yi, Q., Wang, W., Qi, Y., Yang, C., Sui, M., Meng, K., & Zhao, S. (2025) · PeerJ · doi:10.7717/peerj.19588 · Cited by 7
Health Behavior Change to Mitigate Dementia Risk: An Updated Review
Sanborn, V. E., Davis, J. D., & Korthauer, L. E. (2024) · Current Geriatrics Reports · doi:10.1007/s13670-024-00421-y · Cited by 6
Chew, J. L., Zeng, Z., Tan, T. H. B., Chew, P., Ali, N. B., Wang, H., Ong, M., Raymond, R., Pek, K., Wang, D., et al. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph22010042 · Cited by 7
Dodds, L., Deckers, K., Harris, C. B., & Siette, J. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100093 · Cited by 10
Sala, G., Cuffaro, L., Pozzi, F. E., Andreoni, S., Bazzini, C., Conti, E., Zoia, C., Beretta, S., Tremolizzo, L., Bellelli, G., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1581892 · Cited by 8
Kang, H., Ihara, E. S., Tompkins, C. J., & Lauber, M. (2025) · Sage Open Aging · doi:10.1177/30495334251366575 · Cited by 6
Effect modifiers of the MIND diet for cognition in older adults: The MIND diet trial
Halloway, S., Aggarwal, N. T., Arfanakis, K., Sacks, F. M., Barnes, L. L., & Dhana, K. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70731 · Cited by 6
Siette, J., Dodds, L., Brooks, C., & Deckers, K. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1205001 · Cited by 6
Singh, S. S., Zhong, S., Rogers, K. A., Hachinski, V., & Frisbee, S. J. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1290064 · Cited by 6
Balietti, M., Galeazzi, R., Giacconi, R., Santillo, E., & Giuli, C. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230125 · Cited by 6
Dense data enables 21st century clinical trials
Roach, J. C., Hodes, J. F., Funk, C. C., Shankle, W. R., Merrill, D. A., Hood, L., & Bramen, J. E. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12297 · Cited by 6
González-Bautista, E., Soto, M. E., van Kan, G. A., & Delrieu, J. (2025) · GeroScience · doi:10.1007/s11357-024-01497-2 · Cited by 5
Medical risk factors, ApoE haplotype, and Alzheimer’s disease: a large-scale analysis
Elias, U., Gazit, L., Zucker, R., Stern, A., Linial, M., Allali, G., Ben‐Hur, T., Marshall, G. A., & Arzy, S. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100301 · Cited by 7
Cross, A. J., Geethadevi, G. M., Magin, P. J., Baker, A., Bonevski, B., Godbee, K., Ward, S. A., Mahal, A. S., Versace, V. L., Bell, J. S., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-073709 · Cited by 6
Ablinger, I., Dressel, K., Rott, T., Lauer, A. A., Tiemann, M., Batista, J. P., Taddey, T., Grimm, H. S., & Grimm, M. O. W. (2022) · Biomedicines · doi:10.3390/biomedicines10112922 · Cited by 5
Truin, L. S., Köhler, S., Heger, I., van Boxtel, M. P. J., Schram, M. T., Backes, W. H., Jansen, J. F. A., DONGEN, M. C. J. M. V., de Vries, N. K., de Vries, H., et al. (2023) · The British Journal of Psychiatry · doi:10.1192/bjp.2023.159 · Cited by 5
Khalid, N. M., Ponvel, P., Ibrahim, A., Safien, A. M., Fadzil, N. H. M., Singh, D. K. A., Ludin, A. F. M., Ibrahim, N., Subramaniam, P., Haron, H., et al. (2024) · Clinical Interventions in Aging · doi:10.2147/cia.s458600 · Cited by 5
Enhancing Inhibitory Control in Older Adults: A Biofeedback Study
Tinello, D., Tarvainen, M. P., Zuber, S., & Kliegel, M. (2023) · Brain Sciences · doi:10.3390/brainsci13020335 · Cited by 8
Dingle, S. E., Milte, C. M., Daly, R. M., & Torres, S. J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230176 · Cited by 6
Gutiérrez, M., Cabello, V., SanMartín, C. D., Mauro, J., Musa, G., Torres, M., Martín, C. S., Márquez, C., Beltrán, R., Rogers, N., et al. (2025) · JMIR Aging · doi:10.2196/71936 · Cited by 4
The Impact of Lifestyle on Brain Health
Potashkin, J. A., Vidyadhara, D. J., & Hunsberger, H. C. (2025) · American Journal of Lifestyle Medicine · doi:10.1177/15598276251411888 · Cited by 6
Hutmacher, F., & Aufschnaiter, S. (2025) · Health Communication · doi:10.1080/10410236.2025.2460849 · Cited by 4
Estimating the impact of risk factor reduction on dementia prevalence in New Zealand
Ma’u, E., Mukadam, N., Livingston, G., Walsh, S., Röhr, S., Brayne, C., Cheung, G., & Cullum, S. J. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70440 · Cited by 4
The use of inhaled nitric oxide (Tianox device) in patients with moderate cognitive impairment
Starchina, Y. A., Гришина, Д. А., Sokolov, E. A., & Parfenov, V. A. (2023) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2023-6-64-70 · Cited by 4
Alzheimer’s Disease: Engaging with an Unstable Category
Daly, T. P., & Keuck, L. (2024) · Springer eBooks · doi:10.1007/978-94-017-8706-2_113-1 · Cited by 5
Sugimoto, T., Crane, P. K., Choi, S., Fujita, K., Gallée, J., Kuroda, Y., Lee, M. K., Matsumoto, N., Nakamura, A., Noma, H., et al. (2025) · Journal of Aging Research and Lifestyle · doi:10.1016/j.jarlif.2025.100016 · Cited by 3
van Loenen, M. R., Remie, L. B., van Trijp, M. P. H., Jansen, M. G., Marques, J. P., Claassen, J. A. H. R., van de Rest, O., Vermeiren, Y., Smidt, N., Sikkes, S. A. M., et al. (2025) · JMIR Research Protocols · doi:10.2196/69814 · Cited by 8
Ho, H. T., Jia, R. M., Habibi, N., Stern, C., Carter, G., Santin, O., Stone, J., Valenzuela, C., & Aromataris, E. (2024) · JBI Evidence Synthesis · doi:10.11124/jbies-23-00470 · Cited by 3
Middleton, L. E., Bechard, L., Heibein, W., Schneider, L., Shoemaker, M., Roth, G., Wei, C., Koch, M. S., Keller, H., & McAiney, C. A. (2025) · Dementia · doi:10.1177/14713012251325928 · Cited by 3
Wittmann, F., Zülke, A. E., Schultz, A., Claus, M., Röhr, S., Luppa, M., & Riedel-Heller, S. G. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043520 · Cited by 3
Düzel, E., & Thyrian, J. R. (2023) · Der Nervenarzt · doi:10.1007/s00115-023-01478-4 · Cited by 3
Building digital solutions to support brain health prescribing in primary care: Where to begin?
Siette, J., & Adam, P. J. (2024) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12447 · Cited by 3
Zeng, Y., & Zhang, G. (2025) · ALPHA PSYCHIATRY · doi:10.31083/ap38762 · Cited by 3
Effects of Protein Intake on Cognitive Function in Chinese Older Adults: A 10-Year Follow-Up Study
Zheng, T., Zheng, X., Xiao, S., Xue, B., Chen, C., Li, Y., Li, X., & Zhang, C. (2025) · Nutrients · doi:10.3390/nu17020272 · Cited by 4
Beccherle, M., Amato, S., Facci, E., Stefanescu, G., Bertagnoli, S., Francesco, V. D., Fontana, G., Gambina, G., & Moro, V. (2026) · Aging Clinical and Experimental Research · doi:10.1007/s40520-026-03327-1 · Cited by 2
Yu, C. T. K., Livingston, G., Louise, A., Boczko, R., Boex, S., Cho, Y., Forristal, K., Hunter, R. M., Jamison, J., Khatun, F., et al. (2026) · Journal of Medical Internet Research · doi:10.2196/91999 · Cited by 1
Lin, R., Yan, Y., Huang, C., Zhao, J., Chen, M., & Li, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-92535-2 · Cited by 2
van Loenen, M. R., Remie, L. B., van Trijp, M. P. H., Jansen, M. G., Marques, J. P., Claassen, J. A. H. R., van de Rest, O., Vermeiren, Y., Smidt, N., Sikkes, S. A. M., et al. (2024) · doi:10.2196/preprints.69814 · Cited by 2
Pigott, J., Armstrong, M., Tabassum, N., Davies, N., & Schrag, A. E. (2024) · Parkinson s Disease · doi:10.1155/2024/3654652 · Cited by 1
Siette, J., Dodds, L., Brooks, C., Deckers, K., Köhler, S., & Armitage, C. J. (2025) · BMC Public Health · doi:10.1186/s12889-025-21641-7 · Cited by 1
Tullipan, M., George, J., Magin, P. J., Godbee, K., Ferns, J., & Frewin, C. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100187 · Cited by 1
Gidlow, C. J., Mankoo, A. S., Jolly, K. B., & Retzer, A. (2025) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph22060851 · Cited by 3
Erz, D., Schröder, V. E., Skrozic, A., Loureiro, J. M., Possemis, N., & Krüger, R. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1712500 · Cited by 1
Lopes, J. M., Bertuccio, P., Blandi, L., Vecchio, R., & Odone, A. (2026) · Neurology International · doi:10.3390/neurolint18030042 · Cited by 1
Dietary Factors and Cognitive Health in Ethnic Chinese: A Systematic Review and Meta-analysis
Yang, M., Li, Z., Ye, K. X., Guo, J., Lee, T. S., Cao, L., Wang, Y., Ye, R., Maier, A. B., Feng, L., et al. (2026) · Nutrition Reviews · doi:10.1093/nutrit/nuag026 · Cited by 1
Zhao, Y., Zeng, M., Zhang, S., & Peng, D. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1798080 · Cited by 1
Management of patients with mild cognitive impairment: the possibility of using nitric oxide
Parfenov, V. A., Starchina, Y. A., & Grinyuk, V. V. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-208 · Cited by 1
Incidence Rates of Dementia—What Can They Tell Us?
Larson, E. B. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.47289 · Cited by 1
Comparative efficacy of inhaled nitric oxide therapy (Tianox device) in mild cognitive impairment
Гришина, Д. А., Starchina, Y. A., Sokolov, E. A., & Parfenov, V. A. (2024) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2024-6-53-60 · Cited by 1
Are modifiable risk factors for dementia really modifiable?
Ma’u, E., Cullum, S. J., Röhr, S., & Brayne, C. (2025) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000001018 · Cited by 2
Are trailblazing trials for reducing cognitive decline putting the cart before the horse?
Daly, T. P. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12298 · Cited by 1
What are the effects of multi-domain interventions for prevention of dementia and cognitive decline?
Ciapponi, A. (2021) · Cochrane Clinical Answers · doi:10.1002/cca.3883
Metadata
- Authors
- Hafdi, M., Hoevenaar-Blom, M. P., & Richard, E.
- Affiliations
- Amsterdam University Medical Centers (NL)
- Department of Public and Occupational Health; Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands
- Radboud University Nijmegen (NL)
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2021-11-08
- Volume
- 2021
- Issue
- 11
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W4200308390
- Cited by
- 124
- References
- 128
- Citations by year
- 2026: 21 · 2025: 33 · 2024: 30 · 2023: 27 · 2022: 11 · 2021: 2
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- other-oa
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Cognitive Abilities and Testing
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- dementia prevention, cognitive decline, multidomain intervention, older adults, mild cognitive impairment, dementia risk factors, lifestyle intervention, cognitive function, incident dementia, mortality, adverse events, cardiovascular events, risk of bias, quality of evidence, citizen science, non-pharmacological treatment, pharmacological interventions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
